IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET
The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effective innovative drugs and leads to unnecessary ex...
Main Authors: | V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2018-02-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/215 |
Similar Items
-
THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS
by: V. K. Fedyaeva, et al.
Published: (2017-08-01) -
BUDGET NORMALIZATION AND PRICING FEATURES IN CONSTRUCTION
by: M. I. Gadzhieva, et al.
Published: (2016-07-01) -
Impact of regulated price adjustments on price variability in a very low inflation transition economy: Case of Armenia
by: Aghassi Mkrtchyan
Published: (2005-06-01) -
Analyzing Pricing Strategies of MTN-Irancell
by: mohsen nazari, et al.
Published: (2011-02-01) -
PRICE CATEGORIES AND PRICE STRUCTURE
by: VĂDUVA CECILIA ELENA
Published: (2014-02-01)